Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of
this common arrhythmia. Substantial advances in the epidemiology and associated …

Patients aged≥ 65 years not only account for the majority of patients with atrial fibrillation
(AF) and venous thromboembolism (VTE), they are also at a higher risk of morbidity …

Introduction In the USA, there is a steady rise of atrial fibrillation due to the aging population
with increased morbidity. This study evaluated the risk of stroke/systemic embolism (S/SE) …

In recent years, US payers have increased usage of formulary exclusions as a means to
help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the …

Objective To assess potential impacts of formulary tier increases of apixaban—an
efficacious oral anticoagulant (OAC) for preventing stroke in patients with atrial fibrillation …

Background: The co-incidence of multiple morbidities and polypharmacy is common
amongst patients with atrial fibrillation (AF); however, data on their impact on clinical …

Atrial fibrillation (AF) patients are often high risk being elderly and having multiple
comorbidities. Many risk factors are established to be associated with new onset incident AF …